Craft

TCM Biotech

Stock Price

NT$60.2

2024-10-29

Market Capitalization

NT$3.6 B

2024-10-29

Revenue

NT$685.5 M

FY, 2025

TCM Biotech Summary

Company Summary

Overview
TCM Biotech (泰宗生物科技股份有限公司, also known as Taizong Biotechnology) is a biotech company that specializes in the research and development of drugs. It offers medical devices, osteoarthritis treatment products, anti-diabetic preparations, anti-adhesion systems, etc.
Type
Public
Status
Active
Founded
1998
Website
http://www.tcmbio.com
Cybersecurity rating
Sectors

Table of Contents

TCM Biotech Financials

Summary Financials

Revenue (FY, 2025)
NT$685.5M
Gross profit (FY, 2025)
NT$340.7M
Net income (FY, 2025)
NT$19.2M
Cash (FY, 2025)
NT$245.1M
EBIT (FY, 2025)
NT$16.8M
Enterprise value
$3.4B

Footer menu